Clinical Trials Browser

Bronchiolitis Obliterans Syndrome, Bone Marrow Diseases, Hematologic Diseases, Leukemia, Myeloproliferative Disorders, Neoplastic Processes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01490632 2019-09-27

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Phase 2 Completed

271 enrolled 32 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, Plaque, Amyloid

NCT01107457 2019-09-24

A Study in Participants With Moderate to Severe Psoriasis

Phase 2 Completed

142 enrolled 45 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

NCT02908347 2019-01-23

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Phase 2 Completed

46 enrolled 24 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

NCT00077922 2018-01-23

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Phase 2 Completed

15 enrolled 10 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01357655 2017-03-14

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Phase 2 Terminated

70 enrolled 8 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia

NCT01600053 2016-12-15

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Phase 2 Terminated

11 enrolled 4 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Phase 2 Completed

61 enrolled 25 charts

Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

NCT00280241 2016-02-04

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Phase 2 Completed

65 enrolled 8 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00328198 2014-03-13

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

Phase 2 Completed

86 enrolled 15 charts

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

AGAVE-201

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

REACH 5

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

DIALOG

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

A Study in Participants With Moderate to Severe Psoriasis

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia